Literature DB >> 27157979

Synthesis, structural characterization, cytotoxic properties and DNA binding of a dinuclear copper(II) complex.

B J M Leite Ferreira1, P Brandão2, M Meireles3, Fátima Martel4, Ana Correia-Branco4, Diana M Fernandes5, T M Santos1, V Félix6.   

Abstract

In this study a novel dinuclear copper(II) complex with adenine and phenanthroline has been synthesized and its structure determined by single crystal X-ray diffraction. In the dinuclear complex [Cu₂(μ-adenine)₂(phen)₂(H2O)2](NO3)4·0.5H2O (phen=1,10-phenanthroline) (1) the two Cu(II) centres exhibit a distorted square pyramidal coordination geometry linked by two nitrogen donors from adenine bridges leading to a Cu-Cu distance of 3.242(3)Å. Intramolecular and intermolecular π⋯π interactions as well as an H-bonding network were observed. The antitumor capacity of the complex has been tested in vitro against human cancer cell lines, cervical carcinoma (HeLa) and colorectal adenocarcinoma (Caco-2), by metabolic tests, using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide as reagent. The complex 1 has remarkable low IC50 values of 0.87±0.06μM (HeLa) and 0.44±0.06μM (Caco-2), when compared with values for cisplatin against the same cell lines. The interaction of complex 1 with calf thymus DNA (CT DNA) was further investigated by absorption and fluorescence spectroscopic methods. A binding constant of 5.09×10(5)M(-1) was obtained from UV-vis absorption studies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenine; Caco-2; DNA-binding; Dinuclear copper(II) complex; HeLa; Phenanthroline

Mesh:

Substances:

Year:  2016        PMID: 27157979     DOI: 10.1016/j.jinorgbio.2016.04.026

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

Review 1.  Some nontoxic metal-based drugs for selected prevalent tropical pathogenic diseases.

Authors:  Saliu A Amolegbe; Caroline A Akinremi; Sheriff Adewuyi; Amudat Lawal; Mercy O Bamigboye; Joshua A Obaleye
Journal:  J Biol Inorg Chem       Date:  2016-11-30       Impact factor: 3.358

2.  DNA interaction, anticancer, cytotoxicity and genotoxicity studies with potential pyrazine-bipyrazole dinuclear µ-oxo bridged Au(III) complexes.

Authors:  Darshana N Kanthecha; Bhupesh S Bhatt; Mohan N Patel; Foram U Vaidya; Chandramani Pathak
Journal:  Mol Divers       Date:  2021-09-24       Impact factor: 3.364

3.  Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action.

Authors:  Rodica Olar; Mihaela Badea; Mihaela Bacalum; Mina Răileanu; Lavinia L Ruţă; Ileana C Farcaşanu; Arpad Mihai Rostas; Ioana Dorina Vlaicu; Marcela Popa; Mariana Carmen Chifiriuc
Journal:  Biometals       Date:  2021-08-05       Impact factor: 2.949

4.  Copper(II) Complexes with Mixed Heterocycle Ligands as Promising Antibacterial and Antitumor Species.

Authors:  Arpad Mihai Rostas; Mihaela Badea; Lavinia L Ruta; Ileana C Farcasanu; Catalin Maxim; Mariana Carmen Chifiriuc; Marcela Popa; Mirela Luca; Natasa Celan Korosin; Romana Cerc Korosec; Mihaela Bacalum; Mina Raileanu; Rodica Olar
Journal:  Molecules       Date:  2020-08-19       Impact factor: 4.411

5.  Biological Activity of Triazolopyrimidine Copper(II) Complexes Modulated by an Auxiliary N-N-Chelating Heterocycle Ligands.

Authors:  Lavinia L Ruta; Ileana C Farcasanu; Mihaela Bacalum; Mina Răileanu; Arpad Mihai Rostas; Constantin Daniliuc; Mariana Carmen Chifiriuc; Luminița Măruțescu; Marcela Popa; Mihaela Badea; Emilia Elena Iorgulescu; Rodica Olar
Journal:  Molecules       Date:  2021-11-09       Impact factor: 4.411

6.  Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands.

Authors:  Aura Argăseală; Cătălin Maxim; Mihaela Badea; Larisa Ioniță; Mariana Carmen Chifiriuc; Arpad Mihai Rostas; Mihaela Bacalum; Mina Răileanu; Lavinia L Ruţă; Ileana C Farcaşanu; Emilia Elena Iorgulescu; Rodica Olar
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.